NRx Pharmaceuticals Finalizes Purchase Agreement for Unregistered Shares
NRx Pharmaceuticals has recently finalized a significant purchase agreement for unregistered shares at $0.38 per share. Approximately 2.7 million shares ...
Tag: NRXP
NRx Pharmaceuticals Launches HOPE Therapeutics Inc at BIO CEO Investor Conference 2024
NRx Pharmaceuticals has officially launched HOPE Therapeutics, Inc. during the BIO CEO & Investor Conference 2024. The company's management is ...
Don't Miss It
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
